Cargando…
Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
OBJECTIVES: The COVID-19 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of var...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481648/ https://www.ncbi.nlm.nih.gov/pubmed/34711355 http://dx.doi.org/10.1016/j.jval.2021.05.013 |
_version_ | 1784576722369249280 |
---|---|
author | Vandepitte, Sophie Alleman, Tijs Nopens, Ingmar Baetens, Jan Coenen, Samuel De Smedt, Delphine |
author_facet | Vandepitte, Sophie Alleman, Tijs Nopens, Ingmar Baetens, Jan Coenen, Samuel De Smedt, Delphine |
author_sort | Vandepitte, Sophie |
collection | PubMed |
description | OBJECTIVES: The COVID-19 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of various coronavirus disease 2019 policy measures. METHODS: A systematic literature search was conducted in PubMed, Embase, and Web of Science. Health economic evaluations considering both costs and outcomes were included. Their quality was comprehensively assessed using the Consensus Health Economic Criteria checklist. Next, the quality of the epidemiological models was evaluated. RESULTS: A total of 3688 articles were identified (March 2021), of which 23 were included. The studies were heterogeneous with regard to methodological quality, contextual factors, strategies’ content, adopted perspective, applied models, and outcomes used. Overall, testing/screening, social distancing, personal protective equipment, quarantine/isolation, and hygienic measures were found to be cost-effective. Furthermore, the most optimal choice and combination of strategies depended on the reproduction number and context. With a rising reproduction number, extending the testing strategy and early implementation of combined multiple restriction measures are most efficient. CONCLUSIONS: The quality assessment highlighted numerous flaws and limitations in the study approaches; hence, their results should be interpreted with caution because the specific context (country, target group, etc) is a key driver for cost-effectiveness. Finally, including a societal perspective in future evaluations is key because this pandemic has an indirect impact on the onset and treatment of other conditions and on our global economy. |
format | Online Article Text |
id | pubmed-8481648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84816482021-09-30 Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review Vandepitte, Sophie Alleman, Tijs Nopens, Ingmar Baetens, Jan Coenen, Samuel De Smedt, Delphine Value Health Themed Section: COVID-19 OBJECTIVES: The COVID-19 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of various coronavirus disease 2019 policy measures. METHODS: A systematic literature search was conducted in PubMed, Embase, and Web of Science. Health economic evaluations considering both costs and outcomes were included. Their quality was comprehensively assessed using the Consensus Health Economic Criteria checklist. Next, the quality of the epidemiological models was evaluated. RESULTS: A total of 3688 articles were identified (March 2021), of which 23 were included. The studies were heterogeneous with regard to methodological quality, contextual factors, strategies’ content, adopted perspective, applied models, and outcomes used. Overall, testing/screening, social distancing, personal protective equipment, quarantine/isolation, and hygienic measures were found to be cost-effective. Furthermore, the most optimal choice and combination of strategies depended on the reproduction number and context. With a rising reproduction number, extending the testing strategy and early implementation of combined multiple restriction measures are most efficient. CONCLUSIONS: The quality assessment highlighted numerous flaws and limitations in the study approaches; hence, their results should be interpreted with caution because the specific context (country, target group, etc) is a key driver for cost-effectiveness. Finally, including a societal perspective in future evaluations is key because this pandemic has an indirect impact on the onset and treatment of other conditions and on our global economy. ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021-11 2021-09-30 /pmc/articles/PMC8481648/ /pubmed/34711355 http://dx.doi.org/10.1016/j.jval.2021.05.013 Text en © 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Themed Section: COVID-19 Vandepitte, Sophie Alleman, Tijs Nopens, Ingmar Baetens, Jan Coenen, Samuel De Smedt, Delphine Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review |
title | Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review |
title_full | Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review |
title_fullStr | Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review |
title_full_unstemmed | Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review |
title_short | Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review |
title_sort | cost-effectiveness of covid-19 policy measures: a systematic review |
topic | Themed Section: COVID-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481648/ https://www.ncbi.nlm.nih.gov/pubmed/34711355 http://dx.doi.org/10.1016/j.jval.2021.05.013 |
work_keys_str_mv | AT vandepittesophie costeffectivenessofcovid19policymeasuresasystematicreview AT allemantijs costeffectivenessofcovid19policymeasuresasystematicreview AT nopensingmar costeffectivenessofcovid19policymeasuresasystematicreview AT baetensjan costeffectivenessofcovid19policymeasuresasystematicreview AT coenensamuel costeffectivenessofcovid19policymeasuresasystematicreview AT desmedtdelphine costeffectivenessofcovid19policymeasuresasystematicreview |